These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6214989)

  • 21. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
    Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN
    Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and clinical evaluation of moxalactam in infants and children.
    Latif R; Thirumoorthi MC; Buckley JA; Kobos DM; Aravind MK; Kauffman RE; Dajani AS
    Dev Pharmacol Ther; 1981; 3(4):222-31. PubMed ID: 6212231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative pharmacokinetics of moxalactam and other cephalosporins].
    Fourtillan JB; Brisson AM
    Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefotetan (YM09330) in humans.
    Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K
    Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.
    Neu HC; Aswapokee P; Fu KP; Ho I; Matthijssen C
    Clin Pharmacol Ther; 1980 May; 27(5):677-85. PubMed ID: 6245831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of moxalactam in patients with normal and impaired renal function.
    Aronoff GR; Sloan RS; Luft FC
    J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients.
    Fujii R
    Rev Infect Dis; 1982; 4 Suppl():S656-63. PubMed ID: 6218579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
    Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzer.
    Polk RE; Stephens GH
    Am J Hosp Pharm; 1981 Jun; 38(6):866-8. PubMed ID: 6454343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
    Varghese M; Khan AJ; Quaye G; Patel U; Kumar K; Evans HE
    Chemotherapy; 1982; 28(6):417-20. PubMed ID: 6218971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 36. The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam.
    Wise R; Baker S; Wright N; Livingston R
    J Antimicrob Chemother; 1980 May; 6(3):319-22. PubMed ID: 6447137
    [No Abstract]   [Full Text] [Related]  

  • 37. Steady-state moxalactam kinetics: comparisons with other cephalosporins.
    Garzone P; Lyon J; Yu VL; Zuravleff J; Diven W; Pasculle W
    Clin Pharmacol Ther; 1981 Jul; 30(1):86-94. PubMed ID: 6453677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary excretion of moxalactam.
    Martinez OV; Levi JU; Livingstone A; Malinin TI; Zeppa R; Hutson D; Einhorn N
    Antimicrob Agents Chemother; 1981 Aug; 20(2):231-4. PubMed ID: 6456690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental and clinical studies on 6059-S (author's transl)].
    Toyonaga Y; Sugita M; Kurosu Y; Kumagai K; Hori M; Takahashi T
    Jpn J Antibiot; 1981 May; 34(5):764-81. PubMed ID: 6457175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.